Medable Inc., announced Feb. 2 the acquisition of a Denmark-based software company that develops mobile applications for clinical trials.
A leading software provider for patient-centered clinical trials, Medable acquired LEO Innovation Lab’s Omhu A/S, a digital health tech company, to expand its global engineering capabilities, according to a press release.
“LEO Innovation Lab has a strong track record developing transformative patient-centered digital solutions, and the technology and team at Omhu exemplify that," Tim Smith, chief technology officer and co-founder of Medable, said in the release. “We’re thrilled to add Omhu’s patient-centered solutions to our platform, and we welcome the innovative and talented Omhu team to Medable.”
Under the terms of the deal, Medable will take over Omhu mobile apps and oversee 38 people with “significant experience in digital health and artificial intelligence,” according to the release.
“By spinning off Omhu completely in this divestment to Medable, we ensure that the great technologies developed by the highly skilled people in Omhu will reach and help even more people globally and improve their outcomes significantly," CEO of LEO Innovation Lab, Anne Fleischer, said in the release. “We are very proud to have landed this deal with Medable.”
The acquisition expands Medable's European footprint to three, as the company also has a presence in Ireland and Switzerland, the release stated.
“Like Medable, Omhu combines medical and scientific expertise, a thorough understanding of the needs of patients and their doctors, and the research into applying artificial intelligence for the benefits of patients and doctors,” Christian Sejersen, site lead for Medable Copenhagen and the former CEO of Omhu, said in the release. “We couldn’t have found a better home for our team, and we are excited to continue delivering innovation that makes lives better for patients.”